TER
0.60% p.a.
Distribution policy
Accumulating
Replication
Physical
Fund size
GBP 6 m
Holdings
30
Advertisement
Overview
GBP 15.63
28/03/2025 (LSE)
-0.29|-1.82%
daily change
52 weeks low/high
13.85
17.97
Description
The First Trust NYSE Arca Biotechnology UCITS ETF Acc seeks to track the NYSE Arca Biotechnology index. The NYSE Arca Biotechnology index tracks companies operating in the biotechnology industry which are listed on NYSE or Nasdaq.
Documents
Basics
Data
| Index | NYSE Arca Biotechnology |
| Investment focus | Equity, United States, Health Care |
| Fund size | GBP 6 m |
| Total expense ratio | 0.60% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 17.91% |
| Inception/ Listing Date | 27 May 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | First Trust |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | First Trust Advisors L.P. |
| Custodian Bank | The Bank of New York Mellon SA/NV (Dublin Branch) |
| Revision Company | PwC |
| Fiscal Year End | 31 December |
| Swiss representative | Oligo Swiss Fund Services SA |
| Swiss paying agent | Banque Cantonale de Genève |
| Germany | 30% tax rebate |
| Switzerland | No ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
Similar ETFs
This section provides you with information on other ETFs with a similar investment focus to the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our ETF profile? Here you'll find our Questionnaire.
Holdings
Below you find information about the composition of the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
Top 10 Holdings
Weight of top 10 holdings
out of 30
39.29%
| Exelixis | 4.37% |
| ACADIA Pharmaceuticals | 4.23% |
| Natera | 4.19% |
| Neurocrine Biosciences, Inc. | 4.06% |
| argenx | 3.94% |
| Corcept Therapeutics | 3.81% |
| Intra-Cellular Therapies | 3.79% |
| Gilead Sciences, Inc. | 3.74% |
| Incyte Corp. | 3.59% |
| Repligen Corp | 3.57% |
Countries
| United States | 83.52% |
| Ireland | 3.42% |
| Germany | 3.25% |
| Other | 9.81% |
Sectors
| Health Care | 90.19% |
| Other | 9.81% |
As of 31/12/2024
Performance
Returns overview
| YTD | -3.76% |
| 1 month | -6.96% |
| 3 months | -4.29% |
| 6 months | +0.51% |
| 1 year | +5.25% |
| 3 years | +13.84% |
| 5 years | - |
| Since inception (MAX) | -4.52% |
| 2024 | +7.12% |
| 2023 | -3.32% |
| 2022 | +6.81% |
| 2021 | -2.52% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 17.91% |
| Volatility 3 years | 21.98% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.29 |
| Return per risk 3 years | 0.20 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -13.02% |
| Maximum drawdown 3 years | -20.22% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -29.26% |
Rolling 1 year volatility
Stock exchange
Listings
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | FBT | FBT IM FBTINAV | FBT.MI | |
| London Stock Exchange | GBX | FBT | FBT LN FBTINAV | ||
| London Stock Exchange | GBP | - | FBT LN | ||
| London Stock Exchange | USD | FBTU | FBTU LN FBTINAV |
Further information
Further ETFs with similar investment focus
Frequently asked questions
What is the name of FBT?
The name of FBT is First Trust NYSE Arca Biotechnology UCITS ETF Acc.
What is the ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The primary ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc is FBT.
What is the ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc is IE00BL0L0H60.
What are the costs of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The total expense ratio (TER) of First Trust NYSE Arca Biotechnology UCITS ETF Acc amounts to 0.60% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is First Trust NYSE Arca Biotechnology UCITS ETF Acc paying dividends?
First Trust NYSE Arca Biotechnology UCITS ETF Acc is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc is 6m GBP. See the following article for more information about the size of ETFs.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
- Last 30 Days
- Current Month
- Last Month
- YTD
- 1 year
- 3 years
- 5 years
- Custom Range
